We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: COVID triggered most cancers tumors to shrink in mice—new examine
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > COVID triggered most cancers tumors to shrink in mice—new examine
COVID triggered most cancers tumors to shrink in mice—new examine
Health

COVID triggered most cancers tumors to shrink in mice—new examine

Last updated: November 29, 2024 3:33 am
Editorial Board Published November 29, 2024
Share
SHARE

Credit score: Pixabay/CC0 Public Area

An enchanting new examine, revealed within the Journal of Medical Investigation, has revealed an sudden potential advantage of extreme COVID an infection: it could assist shrink most cancers.

This shocking discovering, primarily based on analysis performed in mice, opens up new prospects for most cancers remedy and sheds mild on the complicated interactions between the immune system and most cancers cells—nevertheless it definitely does not imply individuals ought to actively attempt to catch COVID.

The info outlining the significance of the immune system in most cancers is appreciable and plenty of medication goal the immune system, unlocking its potential, an necessary focus of my very own analysis.

The examine right here targeted on a sort of white blood cell known as monocytes. These immune cells play an important function within the physique’s protection towards infections and different threats. Nevertheless, in most cancers sufferers, monocytes can typically be hijacked by tumor cells and reworked into cancer-friendly cells that defend the tumor from the immune system.

What the researchers found was that extreme COVID an infection causes the physique to provide a particular kind of monocyte with distinctive anti-cancer properties. These “induced” monocytes are particularly skilled to focus on the virus, however additionally they retain the power to combat most cancers cells.

To grasp how this works, we have to have a look at the genetic materials of the virus that causes COVID. The researchers discovered that these induced monocytes have a particular receptor that binds effectively to a selected sequence of COVID RNA. Ankit Bharat, one of many scientists concerned on this work from Northwestern College in Chicago defined this relationship utilizing a lock-and-key analogy: “If the monocyte was a lock, and the COVID RNA was a key, then COVID RNA is the perfect fit.”

Exceptional

To check their principle, the analysis group performed experiments on mice with numerous sorts of superior (stage 4) cancers, together with melanoma, lung, breast and colon most cancers. They gave the mice a drug that mimicked the immune response to a extreme COVID an infection, inducing the manufacturing of those particular monocytes. The outcomes had been outstanding. The tumors within the mice started to shrink throughout all 4 sorts of most cancers studied.

Not like common monocytes, which will be transformed by tumors into protecting cells, these induced monocytes retained their cancer-fighting properties. They had been in a position to migrate to the tumor websites—a feat that almost all immune cells can’t accomplish—and, as soon as there, they activated pure killer cells. These killer cells then attacked the most cancers cells, inflicting the tumors to shrink.

This mechanism is especially thrilling as a result of it gives a brand new strategy to combating most cancers that does not depend on T cells, that are the main target of many present immunotherapy therapies.

Whereas immunotherapy has proven promise, it solely works in about 20% to 40% of instances, typically failing when the physique cannot produce sufficient functioning T cells. Certainly it is thought that the reliance on T cell immunity is a serious limitation of present immunotherapy approaches.

This new mechanism, in contrast, gives a technique to selectively kill tumors that’s unbiased of T cells, doubtlessly offering an answer for sufferers who do not reply to conventional immunotherapy.

It is necessary to notice that this examine was performed in mice, and scientific trials will probably be mandatory to find out if the identical impact happens in people.

Perhaps elements of this mechanism might work in people and towards different sorts of most cancers as effectively, because it disrupts a standard pathway that almost all cancers use to unfold all through the physique.

Whereas COVID vaccines are unlikely to set off this mechanism (as they do not use the total RNA sequence because the virus), this analysis opens up prospects for growing new medication and vaccines that might stimulate the manufacturing of those cancer-fighting monocytes.

Educated immunity

The implications of this examine prolong past COVID and most cancers. It reveals how our immune system will be skilled by one kind of menace to develop into simpler towards one other. This idea, generally known as “trained immunity,” is an thrilling space of analysis that might result in new approaches for treating a variety of ailments.

Nevertheless, it is essential once more to emphasise that this does not imply individuals ought to hunt down COVID an infection as a technique to combat most cancers, and that is particularly harmful as I’ve described. Extreme COVID will be life-threatening and has many critical long-term well being penalties.

As a substitute, this analysis gives helpful insights that might result in the event of safer, extra focused therapies sooner or later. As we proceed to grapple with the aftermath of the COVID pandemic, new infections and lengthy COVID, research like this remind us of the significance of primary scientific analysis.

Even within the face of a world well being disaster, researchers are discovering methods to advance our understanding of human biology and illness. This work not solely helps us fight the instant menace of COVID, but additionally paves the way in which for breakthroughs in treating different critical circumstances reminiscent of most cancers.

Whereas there’s nonetheless a lot work to be performed earlier than these findings will be translated into therapies for human sufferers, this examine represents an thrilling step ahead in our understanding of the complicated relationship between viruses, the immune system and most cancers. It gives hope for brand spanking new therapeutic approaches and underscores the customarily sudden methods during which scientific discoveries can result in medical breakthroughs.

Supplied by
The Dialog

This text is republished from The Dialog underneath a Inventive Commons license. Learn the unique article.The Conversation

Quotation:
COVID triggered most cancers tumors to shrink in mice—new examine (2024, November 28)
retrieved 28 November 2024
from https://medicalxpress.com/information/2024-11-covid-cancer-tumors-mice.html

This doc is topic to copyright. Aside from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for data functions solely.

You Might Also Like

Resident-to-resident aggression is frequent in nursing properties. This is how we are able to enhance residents’ security

Higher planning can cut back illness absence amongst shift staff

New AI instrument reimagines infectious illness forecasting, outperforms present state-of-the-art strategies

Lengthy-lasting HIV prevention shot headed towards approval

Girls much less prone to obtain therapy for lethal coronary heart situation

TAGGED:CancercausedCOVIDmicenewshrinkstudyTumors
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
In Mariupol’s Drama Theater, a Cry for ‘Mama!’ That Offered Brief Relief
World

In Mariupol’s Drama Theater, a Cry for ‘Mama!’ That Offered Brief Relief

Editorial Board April 9, 2022
Is it heartburn or a coronary heart situation? an knowledgeable explains
‘Stranger Things 4’: A Guide to the Major Pop Culture References
Jets interviewed Matt Nagy for HC place; Alec Halaby for GM function
Coding variations in Medicare Benefit plans led to $33 billion in extra income to insurers, research finds

You Might Also Like

Single-dose CAR-T remedy doubtlessly healing in a number of myeloma
Health

Single-dose CAR-T remedy doubtlessly healing in a number of myeloma

June 7, 2025
New analysis hyperlinks pores and skin barrier dysfunction to pediatric eosinophilic esophagitis
Health

New analysis hyperlinks pores and skin barrier dysfunction to pediatric eosinophilic esophagitis

June 7, 2025
Nurses cite staffing shortages, language limitations, and revenue focus as key care challenges
Health

Nurses cite staffing shortages, language limitations, and revenue focus as key care challenges

June 7, 2025
Measles outbreaks in Michigan and Pennsylvania finish, whereas Texas logs simply 4 new instances
Health

Measles outbreaks in Michigan and Pennsylvania finish, whereas Texas logs simply 4 new instances

June 7, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?